Send me a link:

*Text messaging rates may apply.

 Dow Down 0.09% Nasdaq Up 0.42%

Rydex Biotechnology C (RYCFX)

63.49 Up 1.36(2.19%) Jul 29
Prev Close:63.49
YTD Return*:12.89%
Net Assets*:400.47M
Yield*:N/A

* As of 30-Jun-14

Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for RYCFX at this time.

Top Holdings

Symbol% AssetsYTD Return %
GILD7.0413.57
AMGN5.886.53
BIIB5.3716.16
CELG5.294.75
ALXN3.3222.51

Fund Basics

Morningstar Overall Rating:
Total Assets:400.47M
Category:Health
Annual Report Expense Ratio (net):2.36%

Performance & Risk

YTD Return:12.89%
5y Avg Return:25.72%
Rank in Category (ytd):24
% Rank in Category (ytd):18.6%
Beta (3y):0.78
Morningstar Risk Rating:5

Fund Summary

The investment seeks to provide capital appreciation. Under normal circumstances, the fund invests substantially all (at least 80%) of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It will invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The fund is non-diversified. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback